Published in Blood Weekly, August 31st, 2000
At a U.S. National Institutes of Health conference held August 15, 2000, speakers said that researchers who have a financial interest in drug companies may bias medical findings, put patients at risk, and erode public trust in the integrity of health science.
"If a crisis in confidence develops, if research subjects no longer feel safe, then medical research will grind to a halt," said Jane Henney, commissioner of the U.S. Food and Drug Administration.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.